Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Alves F, Bilbe G, Blesson S, Goyal V, Monnerat S, Mowbray C, Muthoni Ouattara G, Pécoul B, Rijal S, Rode J, Solomos A, Strub-Wourgaft N, Wasunna M, Wells S, Zijlstra EE, Arana B, Alvar J.

Clin Microbiol Rev. 2018 Aug 29;31(4). pii: e00048-18. doi: 10.1128/CMR.00048-18. Print 2018 Oct. Review.

PMID:
30158301
2.

A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.

López L, Vélez I, Asela C, Cruz C, Alves F, Robledo S, Arana B.

PLoS Negl Trop Dis. 2018 Jul 25;12(7):e0006653. doi: 10.1371/journal.pntd.0006653. eCollection 2018 Jul.

3.

An international qualitative study exploring patients' experiences of cutaneous leishmaniasis: study set-up and protocol.

Erber AC, Arana B, Bennis I, Ben Salah A, Boukthir A, Castro Noriega MDM, Cissé M, Cota GF, Handjani F, Kebede MG, Lang T, López Carvajal L, Marsh K, Martinez Medina D, Plugge E, Olliaro P.

BMJ Open. 2018 Jun 15;8(6):e021372. doi: 10.1136/bmjopen-2017-021372.

4.

Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.

Olliaro P, Grogl M, Boni M, Carvalho EM, Chebli H, Cisse M, Diro E, Fernandes Cota G, Erber AC, Gadisa E, Handjani F, Khamesipour A, Llanos-Cuentas A, López Carvajal L, Grout L, Lmimouni BE, Mokni M, Nahzat MS, Ben Salah A, Ozbel Y, Pascale JM, Rizzo Molina N, Rode J, Romero G, Ruiz-Postigo JA, Gore Saravia N, Soto J, Uzun S, Mashayekhi V, Vélez ID, Vogt F, Zerpa O, Arana B.

PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0006141. doi: 10.1371/journal.pntd.0006141. eCollection 2018 Jan.

5.

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

Zijlstra EE, Alves F, Rijal S, Arana B, Alvar J.

PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877. doi: 10.1371/journal.pntd.0005877. eCollection 2017 Nov. Review.

6.

Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.

Hirve S, Kroeger A, Matlashewski G, Mondal D, Banjara MR, Das P, Be-Nazir A, Arana B, Olliaro P.

PLoS Negl Trop Dis. 2017 Oct 12;11(10):e0005889. doi: 10.1371/journal.pntd.0005889. eCollection 2017 Oct. Review.

7.

Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent.

Olliaro PL, Shamsuzzaman TA, Marasini B, Dhariwal AC, Be-Nazir A, Mondal D, Banjara MR, Das P, Sundar S, Rijal S, Arana B, Alvar J, Argaw D, Peeling RW, Kroeger A, Matlashewski G.

PLoS Negl Trop Dis. 2017 Jan 26;11(1):e0005190. doi: 10.1371/journal.pntd.0005190. eCollection 2017 Jan. No abstract available.

8.

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, Olliaro P.

PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug.

9.

Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.

Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available.

10.

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.

Mondal D, Alvar J, Hasnain MG, Hossain MS, Ghosh D, Huda MM, Nabi SG, Sundar S, Matlashewski G, Arana B.

Lancet Glob Health. 2014 Jan;2(1):e51-7. doi: 10.1016/S2214-109X(13)70118-9. Epub 2013 Dec 5.

11.

Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff.

Maintz EM, Hassan M, Huda MM, Ghosh D, Hossain MS, Alim A, Kroeger A, Arana B, Mondal D.

J Trop Med. 2014;2014:676817. doi: 10.1155/2014/676817. Epub 2014 Jan 21.

12.

Determinants of care seeking for children with pneumonia and diarrhea in Guatemala: implications for intervention strategies.

Bruce N, Pope D, Arana B, Shiels C, Romero C, Klein R, Stanistreet D.

Am J Public Health. 2014 Apr;104(4):647-57. doi: 10.2105/AJPH.2013.301658. Epub 2014 Feb 13.

13.

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, Lapujade O, Buffet P, Alvar J.

PLoS Negl Trop Dis. 2013;7(3):e2130. doi: 10.1371/journal.pntd.0002130. Epub 2013 Mar 21.

14.

Macular hole secondary to toxoplasmic retinochoroiditis.

Arana B, Fonollosa A, Artaraz J, Martinez-Berriotxoa A, Martinez-Alday N.

Int Ophthalmol. 2014 Feb;34(1):141-3. doi: 10.1007/s10792-013-9754-2. Epub 2013 Mar 12.

PMID:
23479051
15.

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.

Huda MM, Hirve S, Siddiqui NA, Malaviya P, Banjara MR, Das P, Kansal S, Gurung CK, Naznin E, Rijal S, Arana B, Kroeger A, Mondal D.

BMC Public Health. 2012 Nov 20;12:1001. doi: 10.1186/1471-2458-12-1001.

16.

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.

Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VN, Das P, Berman J, Arana B.

Trop Med Int Health. 2013 Jan;18(1):96-100. doi: 10.1111/tmi.12015. Epub 2012 Nov 8.

17.

Dengue vector management using insecticide treated materials and targeted interventions on productive breeding-sites in Guatemala.

Rizzo N, Gramajo R, Escobar MC, Arana B, Kroeger A, Manrique-Saide P, Petzold M.

BMC Public Health. 2012 Oct 30;12:931. doi: 10.1186/1471-2458-12-931.

18.

Bacteriological results and leprosy reactions among MB leprosy patients treated with uniform multidrug therapy in China.

Shen J, Bathyala N, Kroeger A, Arana B, Pannikar V, Mou H, Bao X, Yang R, Manickam P, Li W, Zhou M, Want J.

Lepr Rev. 2012 Jun;83(2):164-71.

PMID:
22997692
19.

Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh.

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A, Mondal D.

J Trop Med. 2012;2012:126093. doi: 10.1155/2012/126093. Epub 2012 May 9.

20.

Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial.

Smith KR, McCracken JP, Weber MW, Hubbard A, Jenny A, Thompson LM, Balmes J, Diaz A, Arana B, Bruce N.

Lancet. 2011 Nov 12;378(9804):1717-26. doi: 10.1016/S0140-6736(11)60921-5.

PMID:
22078686
21.

Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh.

Rahman M, Ahmed BN, Faiz MA, Chowdhury MZ, Islam QT, Sayeedur R, Rahman MR, Hossain M, Bangali AM, Ahmad Z, Islam MN, Mascie-Taylor CG, Berman J, Arana B.

Am J Trop Med Hyg. 2011 Jul;85(1):66-9. doi: 10.4269/ajtmh.2011.10-0661.

22.

Intervention to lower household wood smoke exposure in Guatemala reduces ST-segment depression on electrocardiograms.

McCracken J, Smith KR, Stone P, Díaz A, Arana B, Schwartz J.

Environ Health Perspect. 2011 Nov;119(11):1562-8. doi: 10.1289/ehp.1002834. Epub 2011 Jun 13.

23.

Visceral leishmaniasis: elimination with existing interventions.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J.

Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Review.

PMID:
21453873
24.

Drug-drug interaction study to assess the effects of multiple-dose pitavastatin on steady-state warfarin in healthy adult volunteers.

Inagaki Y, Hunt T, Arana B, Gosho M, Morgan R.

J Clin Pharmacol. 2011 Sep;51(9):1302-9. doi: 10.1177/0091270010379811. Epub 2011 Jan 12.

PMID:
21228405
25.

Ambisome plus miltefosine for Indian patients with kala-azar.

Sundar S, Sinha PK, Verma DK, Kumar N, Alam S, Pandey K, Kumari P, Ravidas V, Chakravarty J, Verma N, Berman J, Ghalib H, Arana B.

Trans R Soc Trop Med Hyg. 2011 Feb;105(2):115-7. doi: 10.1016/j.trstmh.2010.10.008. Epub 2010 Dec 3.

PMID:
21129762
26.

Exposure of seasonal migrant workers to Onchocerca volvulus on coffee plantations in Guatemala.

Lindblade KA, Richards M, Richards J, Gonzalez RJ, Cruz-Ortiz N, Zea-Flores G, Morales AL, Sauerbrey M, Castro J, Catú E, Arana B, Richards FO Jr, Klein RE.

Am J Trop Med Hyg. 2009 Sep;81(3):438-42.

PMID:
19706910
27.

Evaluation of a pre-existing, 3-year household water treatment and handwashing intervention in rural Guatemala.

Arnold B, Arana B, Mäusezahl D, Hubbard A, Colford JM Jr.

Int J Epidemiol. 2009 Dec;38(6):1651-61. doi: 10.1093/ije/dyp241. Epub 2009 Jul 2.

28.

Effect of reducing indoor air pollution on women's respiratory symptoms and lung function: the RESPIRE Randomized Trial, Guatemala.

Smith-Sivertsen T, Díaz E, Pope D, Lie RT, Díaz A, McCracken J, Bakke P, Arana B, Smith KR, Bruce N.

Am J Epidemiol. 2009 Jul 15;170(2):211-20. doi: 10.1093/aje/kwp100. Epub 2009 May 14.

PMID:
19443665
29.

Lung function and symptoms among indigenous Mayan women exposed to high levels of indoor air pollution.

Díaz E, Bruce N, Pope D, Lie RT, Díaz A, Arana B, Smith KR, Smith-Sivertsen T.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1372-9.

PMID:
18034961
30.

No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin.

Richards FO Jr, Amann J, Arana B, Punkosdy G, Klein R, Blanco C, Lopez B, Mendoza C, Domínguez A, Guarner J, Maguire JH, Eberhard M.

Am J Trop Med Hyg. 2007 Nov;77(5):878-82.

PMID:
17984346
31.

Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settings.

Bruce N, Weber M, Arana B, Diaz A, Jenny A, Thompson L, McCracken J, Dherani M, Juarez D, Ordonez S, Klein R, Smith KR.

Bull World Health Organ. 2007 Jul;85(7):535-44.

32.

Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala.

Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, Dominguez A, Cruz-Ortiz N, Unnasch TR, Punkosdy GA, Richards J, Sauerbrey M, Castro J, Catú E, Oliva O, Richards FO Jr.

Am J Trop Med Hyg. 2007 Aug;77(2):334-41.

PMID:
17690408
33.

Diagnosis of cutaneous leishmaniasis in Guatemala using a real-time polymerase chain reaction assay and the Smartcycler.

Wortmann G, Hochberg LP, Arana BA, Rizzo NR, Arana F, Ryan JR.

Am J Trop Med Hyg. 2007 May;76(5):906-8.

PMID:
17488914
34.

Eye discomfort, headache and back pain among Mayan Guatemalan women taking part in a randomised stove intervention trial.

Díaz E, Smith-Sivertsen T, Pope D, Lie RT, Díaz A, McCracken J, Arana B, Smith KR, Bruce N.

J Epidemiol Community Health. 2007 Jan;61(1):74-9.

35.

The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala.

Winthrop KL, Proaño R, Oliva O, Arana B, Mendoza C, Dominguez A, Amann J, Punkosdy G, Blanco C, Klein R, Sauerbrey M, Richards F.

Am J Trop Med Hyg. 2006 Dec;75(6):1058-62.

PMID:
17172365
36.

Inorganic particles in the skin of inhabitants of volcanic areas of Central America: their possible immunomodulatory influence in leishmaniasis and leprosy.

Convit J, Ulrich M, Castillo J, De Lima H, Pérez M, Caballero N, Hung J, Arana B, Pérez P.

Trans R Soc Trop Med Hyg. 2006 Aug;100(8):734-9. Epub 2006 Jan 10.

PMID:
16406036
37.

Miltefosine for new world cutaneous leishmaniasis.

Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H.

Clin Infect Dis. 2004 May 1;38(9):1266-72. Epub 2004 Apr 9.

PMID:
15127339
38.

Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala.

Steinberg EB, Mendoza CE, Glass R, Arana B, Lopez MB, Mejia M, Gold BD, Priest JW, Bibb W, Monroe SS, Bern C, Bell BP, Hoekstra RM, Klein R, Mintz ED, Luby S.

Am J Trop Med Hyg. 2004 Jan;70(1):83-8.

PMID:
14971703
39.

Seroprevalence of Trypanosoma cruzi infection among school-age children in the endemic area of Guatemala.

Rizzo NR, Arana BA, Diaz A, Cordon-Rosales C, Klein RE, Powell MR.

Am J Trop Med Hyg. 2003 Jun;68(6):678-82.

PMID:
12887026
40.

The domestic dog, a potential reservoir for Leishmania in the Peten region of Guatemala.

Ryan PR, Arana BA, Ryan JR, Wirtz RA, Wortmann GW, Rizzo NR.

Vet Parasitol. 2003 Jul 10;115(1):1-7.

PMID:
12860062
41.

Chemotherapy of cutaneous leishmaniasis: a review.

Arana B, Rizzo N, Diaz A.

Med Microbiol Immunol. 2001 Nov;190(1-2):93-5. Review.

PMID:
11770121
42.
43.

Inadequate drug advice in the pharmacies of Guatemala and Mexico: the scale of the problem and explanatory factors.

Kroeger A, Ochoa H, Arana B, Diaz A, Rizzo N, Flores W.

Ann Trop Med Parasitol. 2001 Sep;95(6):605-16.

PMID:
11672466
44.

Cutaneous leishmaniasis in Guatemala: people's knowledge, concepts and practices.

Arana BA, Rizzo NR, Navin TR, Klein RE, Kroeger A.

Ann Trop Med Parasitol. 2000 Dec;94(8):779-86.

PMID:
11214096
45.

Evaluation of a standardized leishmanin skin test in Guatemala.

Arana BA, Roca M, Rizzo NR, Mendoza CE, Kroeger A.

Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):394-6.

PMID:
10674085
46.

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, Sette A, Tarleton R.

J Clin Invest. 1998 Sep 1;102(5):1062-71.

47.

First reported outbreak of abdominal angiostrongyliasis.

Kramer MH, Greer GJ, Quiñonez JF, Padilla NR, Hernández B, Arana BA, Lorenzana R, Morera P, Hightower AW, Eberhard ML, Herwaldt BL.

Clin Infect Dis. 1998 Feb;26(2):365-72.

PMID:
9580096
49.

Molecular techniques in the characterization of Leishmania isolates from Central America.

Carreira PF, Maingon R, Ward RD, Noyes H, Ponce C, Belli A, Arana B, Zeledon R, Sousa OE.

Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:31-36.

PMID:
8745925
50.

Supplemental Content

Support Center